DiaMedica Therapeutics (DMAC) Current Leases (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Current Leases came in at $104000.0 in Q1 2026, up 11.83% year-on-year from $93000.0 in Q1 2025, and up 845.45% quarter-over-quarter from $11000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Current Leases (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Current Leases history runs 9 years deep, the most recent figure standing at $104000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 11.83% year-over-year to $104000.0 in Q1 2026; TTM through Mar 2026 was $104000.0, a 11.83% increase from a year earlier, with the FY2025 full-year figure at $11000.0, down 15.38% from the prior year.
- Current Leases climbed to $104000.0 in Q1 2026 per DMAC's latest filing, from $11000.0 in the prior quarter.
- Across five years, Current Leases topped out at $104000.0 in Q1 2026 and bottomed at $2000.0 in Q3 2023.
- The 5-year median for Current Leases is $28000.0 (2022), against an average of $45882.4.
- Across the five-year window, Current Leases surged 4300.0% in 2024 and plunged 85.88% in 2025, its largest moves.
- Year by year, Current Leases stood at $63000.0 in 2022, then advanced by 26.98% to $80000.0 in 2023, then sank by 83.75% to $13000.0 in 2024, then slipped by 15.38% to $11000.0 in 2025, then surged by 845.45% to $104000.0 in 2026.
- Per Business Quant, the three latest DMAC Current Leases figures stand at $104000.0 (Q1 2026), $11000.0 (Q4 2025), and $99000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | 104,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 76,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 63,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 5,000.00 |